Various frameworks have been suggested for assessing the risk associated wi
th continuous toxicity outcomes. The first formulates the affect of exposur
e on the adverse effect via a simple normal model and then computes the ris
k function using tail probabilities from the standard normal distribution.
Because this risk function depends heavily on the assumed model, it may be
sensitive to model misspecification. Recently, a semiparametric approach th
at utilizes an alternative definition of excess risk has been studied. Unfo
rtunately, it is not yet clear how the two approaches relate to one another
. In this article, we investigate a semiparametric normal model in which an
unknown transformation of the adverse response satisfies the linear model.
We demonstrate that this formulation unifies the two existing approaches a
nd allows for a coherent risk analysis of dose-response data. In addition e
stimation and inference procedures for the unknown transformation in the se
miparametric model for the continuous response are developed. These are inc
orporated in novel model-checking procedures, including a formal sup-norm t
est of the simple normal model. A well-known toxicological study of aconiaz
ide, a drug under investigation for treatment of tuberculosis, serves as a
case study for the risk assessment methodology.